2011
DOI: 10.1016/j.fertnstert.2010.09.019
|View full text |Cite
|
Sign up to set email alerts
|

The risk of cytogenetic abnormalities in the late first trimester of pregnancies conceived through assisted reproduction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 25 publications
0
12
0
Order By: Relevance
“…Yet in humans, studies are scarce and less conclusive. In this context when comparing natural and stimulated cycles, no differences have been observed in terms of cleavage capacity [3], oocyte [4], and embryo aneuploidy rate [5], or incidence of aneuploidy in either aborted foetuses [6] or chorionic villus sampling late in the first trimester of pregnancy [7]. …”
Section: Introductionmentioning
confidence: 99%
“…Yet in humans, studies are scarce and less conclusive. In this context when comparing natural and stimulated cycles, no differences have been observed in terms of cleavage capacity [3], oocyte [4], and embryo aneuploidy rate [5], or incidence of aneuploidy in either aborted foetuses [6] or chorionic villus sampling late in the first trimester of pregnancy [7]. …”
Section: Introductionmentioning
confidence: 99%
“…Assisted reproductive technology has been associated with adverse pregnancy outcomes, including earlier delivery of pregnancies, low birth weight, very low birth weight, preterm delivery, and other potential complications associated with abnormal placentation (15,16), but not cytogenetic genetic abnormalities, in AMA women compared with spontaneous conceptions (17). More recently, studies have emerged that the underlying infertility and time to pregnancy are risk factors for adverse pregnancy outcomes, independent of maternal age (18).…”
mentioning
confidence: 99%
“…Although the majority of children born through fertility treatments are healthy, these treatments have been associated with adverse pregnancy outcomes including but not limited to preeclampsia, placental abruption, placenta previa, preterm labor and delivery, and low birth weight (3)(4)(5)(6)(7)(8)(9). Although several studies have reported increased risks, it does not appear to be related to an increased risk of cytogenetic abnormalities in pregnancies conceived by assisted reproduction technologies (ART) (10,11). Thus, it has not been fully elucidated how and when these changes are initiated.…”
mentioning
confidence: 99%